The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
Official Title: A Multicenter, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study to Evaluate the Safety and Efficacy of 0.005%, 0.01% and 0.015% PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
Study ID: NCT00700063
Brief Summary: This Phase IIb study is designed to assess the safety and efficacy of 0.005%, 0.01% and 0.015% PEP005 Topical Gel when applied to an area of skin, containing 4-8 AK lesions on the face or scalp.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Burke Pharmaceutical Research, Hot Springs, Arizona, United States
Dermatology Research of Arkansas, Little Rock, Arkansas, United States
Koppel Dermatology, Los Angeles, California, United States
Dermatology Research Associates, Los Angeles, California, United States
Integrated Research Group Inc, Riverside, California, United States
Skin Surgery Medical Group Inc, San Diego, California, United States
470 Castro St Suite 202-204, San Francisco, California, United States
Solano Clinical Research, Vallejo, California, United States
Dermatology Specialists Inc, Vista, California, United States
Spencer Derm and Skin Surgery Center, St Petersburg, Florida, United States
Northwest Clinical Trial, Boise, Idaho, United States
Altman Dermatology Associates, Arlington Heights, Illinois, United States
Christie Clinic, Champaign, Illinois, United States
South Bend Clinic, South Bend, Indiana, United States
Minnesota Clinical Study Center, Fridley, Minnesota, United States
TKL Research, Inc., Paramus, New Jersey, United States
Academic Dermatology Associates, Albuquerque, New Mexico, United States
Oregon Medical Research Center, Portland, Oregon, United States
Philadelphia Institute of Dermatology, Philadelphia, Pennsylvania, United States
Dermatology Research Associates, Nashville, Tennessee, United States
DermResearch, Inc. 8140 N. MoPac, Bldg. 3, Suite 120,, Austin, Texas, United States
Suzanne Bruce and Associates, The Center for Skin Research, Houston, Texas, United States
Dermatology Clinical Research Center of San Antonio, San Antonio, Texas, United States
Progressive Clinical Research, San Antonio, Texas, United States
Dermatology Associates of Tyler, Tyler, Texas, United States
Southderm Pty Ltd, Kogarah, New South Wales, Australia
The Skin Centre, Benowa, Queensland, Australia
Siller Medical, Brisbane, Queensland, Australia